Showing results (1231-1240 of 1,295) with videos related to

Sort By:
Pageof 130
Cancer Research|April 20, 2019
MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt LymphomaJennifer Hüllein, Mikołaj Słabicki, Maciej Rosolowski, et al.
Nature Medicine|November 21, 2018
Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphomaRishu Agarwal, Yih-Chih Chan, Constantine S Tam, et al.
Cancer Research|August 24, 2012
Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical featuresAlba Navarro, Guillem Clot, Cristina Royo, et al.
The Lancet. Respiratory Medicine|November 28, 2025
Multidimensional prognostic risk stratification of COPD exacerbations: the baseline, acuity, and trigger (BAt) modelHnin W W Aung, Kristina Vermeersch, Hamish J C McAuley, et al.
American Heart Journal|November 2, 2025
PRospective evaluation of the European Society of Cardiology 0/1h-algorithm`s safety and efficacy for triage of patients with suspected myocardial infarction (PRESC1SE-MI): Rationale and design of a prospective international multicenter stepped-wedge cluster randomized controlled trialJasper Boeddinghaus, Paolo Bima, Luca Crisanti, et al.
Investigative Ophthalmology & Visual Science|July 5, 2018
The Common ABCA4 Variant p.Asn1868Ile Shows Nonpenetrance and Variable Expression of Stargardt Disease When Present in trans With Severe VariantsEsmee H Runhart, Riccardo Sangermano, Stéphanie S Cornelis, et al.
Leukemia|November 3, 2025
Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trialMouhamad Khouja, Elisa Genuardi, Simone Ferrero, et al.
Ophthalmology|January 24, 2012
Clinical course, genetic etiology, and visual outcome in cone and cone-rod dystrophyAlberta A H J Thiadens, T My Lan Phan, Renate C Zekveld-Vroon, et al.
Leukemia|April 27, 2024
The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma-a randomized, open-label phase III trial of the European mantle cell lymphoma networkLuca Fischer, Linmiao Jiang, Jan Dürig, et al.
European Journal of Human Genetics : EJHG|February 23, 2017
Diagnostic exome sequencing in 266 Dutch patients with visual impairmentLonneke Haer-Wigman, Wendy Ag van Zelst-Stams, Rolph Pfundt, et al.
Pageof 130